Key result
Higher waist circumference linked to ~14% greater postmenopausal breast cancer risk independently of BMI.
Why the study?
Associations between central and peripheral adiposity and postmenopausal breast cancer risk have been inconsistent after adjustment for body mass index.
Does higher central and peripheral adiposity increase the risk of postmenopausal breast cancer in postmenopausal women?
Does higher central and peripheral adiposity increase the risk of postmenopausal breast cancer in postmenopausal women?
Higher waist circumference and waist-to-hip ratio are associated with an increased risk of postmenopausal breast cancer, independent of BMI.
Supports central adiposity measures in postmenopausal breast cancer risk assessment; extends traditional BMI-focused models.
Background: Central and peripheral adiposity, measured by waist circumference (WC), hip circumference (HC), and waist-to-hip ratio (WHR), has been positively associated with postmenopausal breast cancer (BC) risk, but results are inconsistent after adjustment for body mass index (BMI). Using pooled individual-level data from 11 prospective cohorts, we evaluated associations between WC, HC, WHR, and a body shape index (ABSI; based on waist, height, and weight) and risk of postmenopausal BC overall and BC subtypes defined by receptor status. Methods: These preliminary analyses evaluated associations between WC, HC, WHR, and ABSI using consortium-wide quintiles and overall BC and tumor negative breast cancer (TNBC) in 402,682 postmenopausal women. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (95% CI), adjusting for age, year of questionnaire, study, family history of BC, and reproductive and lifestyle factors. Analyses were performed with and without adjustment for BMI. Results: During a median follow-up of 2.9-27.5 years across studies, 20,752 incident invasive BC were documented (N=998 TNBC). The pooled multivariable BMI-adjusted HRs (95% CIs) for postmenopausal BC comparing quintile 5 to 2 were 1.14 (1.08-1.21) for WC; 1.06 (0.99-1.14) for HC; 1.10 (1.05-1.15) for WHR, and 1.03 (0.98-1.08) for ABSI. Similar associations were observed among never-users of menopausal hormone therapy. The pooled multivariable BMI-adjusted HRs (95% CIs) for postmenopausal TNBC comparing quintile 5 to 2 were 1.13 (0.87-1.46) for WC; 0.74 (0.45-1.21) for HC; 1.45 (1.15-1.84) for WHR, and 1.18 (0.95-1.47) for ABSI. Conclusion: Higher compared to lower WC and WHR were associated with increased risk of postmenopausal BC, independent of BMI. Our findings suggest that individual and population-level strategies to prevent central adiposity could help reduce the risk of postmenopausal BC. Citation Format: Isaias Leon-Cepeda, Craigg Pickett, Stephanie A. Smith-Warner, Robert J. MacInnis, Jeanine M. Genkinger. Central and peripheral adiposity and breast cancer risk in postmenopausal women: A pooled analysis of 11 cohort studies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3625.
No takes yet. Share an insight, caveat, or question.
Cepeda et al. (2026) studied this question. Higher waist circumference and waist-to-hip ratio increased postmenopausal breast cancer risk independently of BMI, with adjusted HRs of 1.14 and 1.10 (quintile 5 vs 2).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: